Literature DB >> 33395433

Three dimensional cultivation increases chemo- and radioresistance of colorectal cancer cell lines.

Jana Koch1,2, Dina Mönch1,2, Annika Maaß1,2, Christian Gromoll3,4,5, Thomas Hehr3,4, Tobias Leibold6, Hans J Schlitt7, Marc-H Dahlke6, Philipp Renner6,7.   

Abstract

Although 2D cell cultures are commonly used to predict therapy response, it has become clear that 3D cultures may better mimic the in vivo situation and offer the possibility of tailoring translational clinical approaches. Here, we compared the response of 2D and 3D colorectal cancer (CRC) cell lines to irradiation and chemotherapy. Classic 2D cultures and 3D spheroids of CRC cell lines (CaCo2, Colo205, HCT116, SW480) were thoroughly established, then irradiated with doses of 1, 4, or 10 Gy, using a clinical-grade linear accelerator. The response was assessed by immunohistochemistry, flow cytometry, and TUNEL assays. Upon irradiation, CRC 3D spheroids were morphologically altered. After irradiation with 10 Gy, annexin V/PI staining revealed a 1.8- to 4-fold increase in the apoptosis rate in the 2D cell cultures (95% CI 3.24±0.96), and a 1.5- to 2.4-fold increase in the 3D spheroids (95% CI 1.56±0.41). Irradiation with 1 Gy caused 3- and 4-fold increases in TUNEL positive cells in the CaCo2 and HCT116 (p = 0.01) 2D cultures, respectively, compared with a 2-fold increase in the 3D spheroids. Furthermore, the 2D and 3D cultures responded differently to chemotherapy; the 3D cultures were more resistant to 5-FU and cisplatin, but not to doxorubicin and mitomycin C, than the 2D cultures. Taken together, CRC cells cultured as 3D spheroids displayed markedly higher resistance to irradiation therapy and selected chemotherapeutic drugs than 2D cultures. This in vitro difference must be considered in future approaches for determining the ideal in vitro systems that mimic human disease.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33395433      PMCID: PMC7781370          DOI: 10.1371/journal.pone.0244513

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  26 in total

1.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

2.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

3.  Radiation sensitivity assay with a panel of patient-derived spheroids of small cell carcinoma of the cervix.

Authors:  Aya Nakajima; Hiroko Endo; Hiroaki Okuyama; Yumiko Kiyohara; Tadashi Kimura; Shoji Kamiura; Masahiro Hiraoka; Masahiro Inoue
Journal:  Int J Cancer       Date:  2014-12-11       Impact factor: 7.396

4.  Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy.

Authors:  Didier Cowen; Patricia Troncoso; Vincent S Khoo; Gunar K Zagars; Andrew C von Eschenbach; Marvin L Meistrich; Alan Pollack
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

5.  The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer.

Authors:  Kenny Chitcholtan; Peter H Sykes; John J Evans
Journal:  J Transl Med       Date:  2012-03-06       Impact factor: 5.531

6.  Correlation between the Ki-67 proliferation index and response to radiation therapy in small cell lung cancer.

Authors:  Naoya Ishibashi; Toshiya Maebayashi; Takuya Aizawa; Masakuni Sakaguchi; Haruna Nishimaki; Shinobu Masuda
Journal:  Radiat Oncol       Date:  2017-01-13       Impact factor: 3.481

7.  The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance.

Authors:  Susan Breslin; Lorraine O'Driscoll
Journal:  Oncotarget       Date:  2016-07-19

8.  Automated spheroid generation, drug application and efficacy screening using a deep learning classification: a feasibility study.

Authors:  Leo Benning; Andreas Peintner; Günter Finkenzeller; Lukas Peintner
Journal:  Sci Rep       Date:  2020-07-06       Impact factor: 4.379

9.  Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids.

Authors:  Sylvain L'Espérance; Magdalena Bachvarova; Bernard Tetu; Anne-Marie Mes-Masson; Dimcho Bachvarov
Journal:  BMC Genomics       Date:  2008-02-26       Impact factor: 3.969

Review 10.  Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer.

Authors:  Stephan Paschke; Sakhavat Jafarov; Ludger Staib; Ernst-Dietrich Kreuser; Catharina Maulbecker-Armstrong; Marc Roitman; Torbjörn Holm; Curtis C Harris; Karl-Heinrich Link; Marko Kornmann
Journal:  Int J Mol Sci       Date:  2018-08-30       Impact factor: 5.923

View more
  9 in total

1.  A Micro-Immunotherapy Sequential Medicine MIM-seq Displays Immunomodulatory Effects on Human Macrophages and Anti-Tumor Properties towards In Vitro 2D and 3D Models of Colon Carcinoma and in an In Vivo Subcutaneous Xenograft Colon Carcinoma Model.

Authors:  Camille Jacques; Irene Marchesi; Francesco Paolo Fiorentino; Mathias Chatelais; Nicoletta Libera Lilli; Kurt Appel; Beatrice Lejeune; Ilaria Floris
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

2.  Recapitulating Tumor Microenvironment Using AXTEX-4DTM for Accelerating Cancer Research and Drug Screening.

Authors:  Ambica Baru; Saumyabrata Mazumder; Prabuddha K Kundu; Swati Sharma; Biswa Pratim Das Purkayastha; Sameena Khan; Reeshu Gupta; Nupur Mehrotra Arora
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

Review 3.  Precision Oncology Beyond Genomics: The Future Is Here-It Is Just Not Evenly Distributed.

Authors:  Ulrike Pfohl; Alina Pflaume; Manuela Regenbrecht; Sabine Finkler; Quirin Graf Adelmann; Christoph Reinhard; Christian R A Regenbrecht; Lena Wedeken
Journal:  Cells       Date:  2021-04-17       Impact factor: 6.600

4.  Stromal Cells Promote Matrix Deposition, Remodelling and an Immunosuppressive Tumour Microenvironment in a 3D Model of Colon Cancer.

Authors:  Niamh A Leonard; Eileen Reidy; Kerry Thompson; Emma McDermott; Eleonora Peerani; Elena Tomas Bort; Frances R Balkwill; Daniela Loessner; Aideen E Ryan
Journal:  Cancers (Basel)       Date:  2021-11-29       Impact factor: 6.639

5.  Structural Optimization and Biological Activity of Pyrazole Derivatives: Virtual Computational Analysis, Recovery Assay and 3D Culture Model as Potential Predictive Tools of Effectiveness against Trypanosoma cruzi.

Authors:  Lorraine Martins Rocha Orlando; Guilherme Curty Lechuga; Leonardo da Silva Lara; Byanca Silva Ferreira; Cynthia Nathalia Pereira; Rafaela Corrêa Silva; Maurício Silva Dos Santos; Mirian Claudia S Pereira
Journal:  Molecules       Date:  2021-11-08       Impact factor: 4.411

6.  Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models.

Authors:  Victoria Heredia-Soto; Javier Escudero; María Miguel; Patricia Ruiz; Alejandro Gallego; Alberto Berjón; Alicia Hernández; Marta Martínez-Díez; Shuyu Zheng; Jing Tang; David Hardisson; Jaime Feliu; Andrés Redondo; Marta Mendiola
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 6.244

7.  Synthesis of Novel Lipophilic Polyamines via Ugi Reaction and Evaluation of Their Anticancer Activity.

Authors:  Artemiy Nichugovskiy; Varvara Maksimova; Ekaterina Trapeznikova; Elizaveta Eshtukova-Shcheglova; Igor Ivanov; Marianna Yakubovskaya; Kirill Kirsanov; Dmitry Cheshkov; Gian Cesare Tron; Mikhail Maslov
Journal:  Molecules       Date:  2022-09-21       Impact factor: 4.927

8.  An Integrated Analysis of the Response of Colorectal Adenocarcinoma Caco-2 Cells to X-Ray Exposure.

Authors:  Isabella Guardamagna; Leonardo Lonati; Monica Savio; Lucia A Stivala; Andrea Ottolenghi; Giorgio Baiocco
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

9.  Lineage-specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture.

Authors:  Chiara Liverani; Alessandro De Vita; Chiara Spadazzi; Giacomo Miserocchi; Claudia Cocchi; Alberto Bongiovanni; Anna De Lucia; Federico La Manna; Francesco Fabbri; Michela Tebaldi; Dino Amadori; Ennio Tasciotti; Giovanni Martinelli; Laura Mercatali; Toni Ibrahim
Journal:  Mol Oncol       Date:  2021-07-10       Impact factor: 6.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.